• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚果民主共和国妇幼保健经济激励措施的经济评估:基于整群随机对照试验的决策树建模

Economic evaluation of financial incentives for maternal and child health in the Democratic Republic of the Congo (DRC): a decision-tree modelling based on a cluster randomized controlled trial.

作者信息

Zeng Wu, Shapira Gil, Gao Tianjiao, Muvudi Michel, Li Guohong, Bouey Jennifer, Antwisi Delphin, Yamani Fatma El Kadiri El

机构信息

Department of Global Health, Georgetown University, Washington, DC, USA.

World Bank, Washington, DC, USA.

出版信息

Glob Health Res Policy. 2025 Sep 1;10(1):41. doi: 10.1186/s41256-025-00435-9.

DOI:10.1186/s41256-025-00435-9
PMID:40890822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400745/
Abstract

BACKGROUND

To improve the utilization of maternal and child health (MCH) services, the Democratic Republic of the Congo initiated a performance-based financing (PBF) program in 2017. An impact evaluation of the PBF program was conducted in 2023 using a cluster randomized controlled trial research design. This study aimed to assess the cost-effectiveness of the PBF program in comparison with the direct facility financing (DFF) program.

METHODS

A decision-tree model incorporating key MCH services was developed to estimate cost-effectiveness. Data on costs of maternal health services, epidemiological consequences, and utilities of various health statuses were obtained from the literature. The impact evaluation results on the coverage of key MCH services were included as key inputs to simulate the effectiveness measured as quality-adjusted life years (QALYs). Sensitivity analyses were conducted on the inclusion of the PBF's impact on the quality of care and the uncertainty regarding the costs and the impact of PBF on MCH services.

RESULTS

A total of US$205.9 million in 2021 dollar was spent on the PBF arm over the five years (2017-2021), with 70.60% allocated as incentive payments to health facilities and 19.41% as financial transfers to provincial purchasing agencies for contracting PBF facilities and managing the PBF program. On average, the annual cost per capita was estimated at US$2.05 and US$1.71 for implementing the PBF and DFF program, respectively. Without the quality adjustment, the improvement in MCH services resulted in 1,372 lives (192,036 QALYs) saved over 2017-2021. The incremental cost-effectiveness ratio (ICER) of the PBF program reached US$ 1,374 per QALY with substantial variation. After adjusting for quality, the ICER of PBF became smaller.

CONCLUSIONS

Using three times the gross domestic product per capita in 2021 (US$1,732) as the threshold, the PBF program is a cost-effective strategy, though with substantial variation. It is crucial to take action to maintain gains from the improved MCH coverage resulting from the PBF program.

摘要

背景

为提高妇幼保健(MCH)服务的利用率,刚果民主共和国于2017年启动了基于绩效的融资(PBF)计划。2023年采用整群随机对照试验研究设计对PBF计划进行了影响评估。本研究旨在评估PBF计划与直接设施融资(DFF)计划相比的成本效益。

方法

开发了一个包含关键妇幼保健服务的决策树模型来估计成本效益。从文献中获取了孕产妇保健服务成本、流行病学后果以及各种健康状况效用的数据。对关键妇幼保健服务覆盖范围的影响评估结果作为关键输入,以模拟以质量调整生命年(QALYs)衡量的有效性。对PBF对护理质量的影响以及PBF对妇幼保健服务成本和影响的不确定性进行了敏感性分析。

结果

在2017 - 2021年的五年中,PBF组以2021年美元计算共支出2.059亿美元,其中70.60%作为激励支付给卫生设施,19.41%作为财政转移支付给省级采购机构,用于与PBF设施签约和管理PBF计划。实施PBF和DFF计划的人均年成本估计分别为2.05美元和1.71美元。在未进行质量调整的情况下,2017 - 2021年期间妇幼保健服务的改善挽救了1372条生命(192,036个QALYs)。PBF计划的增量成本效益比(ICER)达到每QALY 1374美元,存在较大差异。在进行质量调整后,PBF的ICER变小。

结论

以2021年人均国内生产总值的三倍(1732美元)作为阈值,PBF计划是一种具有成本效益的策略,尽管存在较大差异。采取行动维持PBF计划带来的妇幼保健覆盖率提高所取得的成果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/9809278a03c4/41256_2025_435_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/2887967964ef/41256_2025_435_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/30eaea4ca876/41256_2025_435_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/8800b3b2938b/41256_2025_435_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/9809278a03c4/41256_2025_435_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/2887967964ef/41256_2025_435_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/30eaea4ca876/41256_2025_435_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/8800b3b2938b/41256_2025_435_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f34/12400745/9809278a03c4/41256_2025_435_Fig4_HTML.jpg

相似文献

1
Economic evaluation of financial incentives for maternal and child health in the Democratic Republic of the Congo (DRC): a decision-tree modelling based on a cluster randomized controlled trial.刚果民主共和国妇幼保健经济激励措施的经济评估:基于整群随机对照试验的决策树建模
Glob Health Res Policy. 2025 Sep 1;10(1):41. doi: 10.1186/s41256-025-00435-9.
2
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
3
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
4
Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.腹腔镜手术治疗结直肠癌的临床疗效与成本效益:系统评价与经济学评估
Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv. doi: 10.3310/hta10450.
5
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
6
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
7
The effect of financial incentives on the quality of health care provided by primary care physicians.经济激励措施对初级保健医生所提供医疗服务质量的影响。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD008451. doi: 10.1002/14651858.CD008451.pub2.
8
Paying for performance to improve the delivery of health interventions in low- and middle-income countries .通过绩效付费来改善低收入和中等收入国家的卫生干预措施提供情况 。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD007899. doi: 10.1002/14651858.CD007899.pub2.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Cost-effectiveness of implementing performance-based financing for improving maternal and child health in Ethiopia.实施基于绩效的筹资以改善埃塞俄比亚母婴健康的成本效益。
PLoS One. 2024 Jul 15;19(7):e0305698. doi: 10.1371/journal.pone.0305698. eCollection 2024.
2
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation.在马拉维实施建立精神卫生保健能力的策略:一项健康经济学评价。
Lancet Glob Health. 2024 Apr;12(4):e662-e671. doi: 10.1016/S2214-109X(23)00597-1. Epub 2024 Feb 23.
3
Caesarean section rate reduced by a redesigned birthing room. Results of a quality improvement intervention at a hospital in Democratic Republic of Congo.
剖宫产率通过重新设计的分娩室降低。刚果民主共和国一家医院的质量改进干预措施的结果。
Sex Reprod Healthc. 2024 Mar;39:100925. doi: 10.1016/j.srhc.2023.100925. Epub 2023 Nov 21.
4
Impacts of performance-based financing on health system performance: evidence from the Democratic Republic of Congo.基于绩效的融资对卫生系统绩效的影响:来自刚果民主共和国的证据。
BMC Med. 2023 Oct 4;21(1):381. doi: 10.1186/s12916-023-03062-8.
5
Reviewing the evidence on health financing for effective coverage: do financial incentives work?审视有效覆盖范围的卫生筹资证据:经济激励是否有效?
BMJ Glob Health. 2022 Sep;7(9). doi: 10.1136/bmjgh-2022-009932.
6
Is Performance-Based Financing A Pathway to Strategic Purchasing in Sub-Saharan Africa? A Synthesis of the Evidence.基于绩效的融资是否是撒哈拉以南非洲战略采购的途径?证据综合。
Health Syst Reform. 2022 Mar 1;8(2):e2068231. doi: 10.1080/23288604.2022.2068231.
7
Maternal mortality study in the Eastern Democratic Republic of the Congo.刚果(金)东部孕产妇死亡率研究。
BMC Pregnancy Childbirth. 2022 May 31;22(1):452. doi: 10.1186/s12884-022-04783-z.
8
Competent and deficient provision of childbirth services: a descriptive observational study assessing the quality of intrapartum care in two provinces of the Democratic Republic of the Congo.有能力和有缺陷的分娩服务提供:一项描述性观察研究,评估刚果民主共和国两个省份的产时护理质量。
BMC Health Serv Res. 2022 Apr 25;22(1):551. doi: 10.1186/s12913-022-07737-5.
9
Assessing the cost-effectiveness of contraceptive methods from a health provider perspective: case study of Kiambu County Hospital, Kenya.从卫生服务提供者角度评估避孕方法的成本效益:肯尼亚基安布县医院案例研究。
Reprod Health. 2022 Jan 17;19(1):11. doi: 10.1186/s12978-021-01308-3.
10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.《2022 年健康经济评估报告标准》(CHEERS 2022)声明:健康经济评估报告的更新指南。
Value Health. 2022 Jan;25(1):3-9. doi: 10.1016/j.jval.2021.11.1351.